Page last updated: 2024-11-07

fistularin 3

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

fistularin 3: structure given in first source; isolated from the marine sponge Aplysina archeri [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10260646
CHEMBL ID470534
MeSH IDM0205064

Synonyms (3)

Synonym
fistularin 3
CHEMBL470534
(5s,6r)-7,9-dibromo-n-[3-[2,6-dibromo-4-[2-[[(5r,6s)-7,9-dibromo-6-hydroxy-8-methoxy-1-oxa-2-azaspiro[4.5]deca-2,7,9-triene-3-carbonyl]amino]-1-hydroxyethyl]phenoxy]-2-hydroxypropyl]-6-hydroxy-8-methoxy-1-oxa-2-azaspiro[4.5]deca-2,7,9-triene-3-carboxamide
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID334755Cytotoxicity against cat CRFK cells assessed as reduction in cell viability after 5 days by MTT assay1992Journal of natural products, Apr, Volume: 55, Issue:4
Fistularin 3 and 11-ketofistularin 3. Feline leukemia virus active bromotyrosine metabolites from the marine sponge Aplysina archeri.
AID334753Antiviral activity against Feline leukemia virus infected in cat CRFK cells assessed as inhibition of viral replication after 7 days by ELISA1992Journal of natural products, Apr, Volume: 55, Issue:4
Fistularin 3 and 11-ketofistularin 3. Feline leukemia virus active bromotyrosine metabolites from the marine sponge Aplysina archeri.
AID334754Ratio of ID50 for cat CRFK cells to ED50 for Feline leukemia virus1992Journal of natural products, Apr, Volume: 55, Issue:4
Fistularin 3 and 11-ketofistularin 3. Feline leukemia virus active bromotyrosine metabolites from the marine sponge Aplysina archeri.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's1 (16.67)29.6817
2010's3 (50.00)24.3611
2020's1 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]